G

Grand Pharmaceutical (China) Co., Ltd.

15 employees

This company is an investment holding company.

Investor insights

Sectors invested in

Medical Device4
Therapeutics3
Health Care3
Biopharma1
Pharmaceutical1
Biotechnology1
Life Science1
Manufacturing1
Medical1
Driving force to establish global standards regarding safety and efficacy of radiopharmaceuticals1
Theranostic radioisotope platform technologies1
Global network to guarantee security of supply1
Strategic alliances in order to further develop Theranostics1

Funding rounds participated in

$28M sweet spot round size

Most of their 7 investments are in rounds between $25M and $34M

Basic info

Sectors

Pharmaceutical

Date founded

1995

Investments made

X

Xeltis raised $34M on February 21, 2023

Investors: DaVita Venture Group, EQT Life Sciences, Invest-NL and Grand Pharmaceutical (China) Co., Ltd.

X

Xeltis raised $15M on August 9, 2022

Investors: Grand Pharmaceutical (China) Co., Ltd.

I

ITM Isotopen Technologien München AG raised $28M on February 16, 2022

Investors: Grand Pharmaceutical (China) Co., Ltd.

I

InnovHeart S.r.l. raised $55M on January 27, 2022

Investors: PANAKES, Indaco Venture Partners and Grand Pharmaceutical (China) Co., Ltd.

C

CoRISMA Cardiovascular raised $27M on August 30, 2021

Investors: Grand Pharmaceutical (China) Co., Ltd.

U

Undisclosed raised $38M on June 16, 2020

Investors: Novalis LifeSciences LLC, BNP Paribas Investment Partners, FundPlus, Omega Funds and Grand Pharmaceutical (China) Co., Ltd.

U

Undisclosed raised $25M on April 17, 2020

Investors: Bank of China International, 一村资本V-Capital and Grand Pharmaceutical (China) Co., Ltd.

FAQ